Denali Therapeutics Inc (DNLI) — Net Asset Quality Index
Denali Therapeutics Inc (DNLI) has a Net Asset Quality Index of 73.2% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $1.27 Billion minus total liabilities of $339.93 Million yields net assets of $926.10 Million. A higher index indicates a stronger, lower-leverage balance sheet. See Denali Therapeutics Inc (DNLI) defensive interval to measure how many days the company can operate on defensive assets alone.
Quality Index
Net Assets
Total Assets
Total Liabilities
Denali Therapeutics Inc Net Asset Quality Index Over Time (2015–2025)
This chart shows how Denali Therapeutics Inc's Net Asset Quality Index has evolved across 11 annual periods from 2015 to 2025. As of March 2026, the index stands at 73.2%, representing net assets of $926.10 Million against total assets of $1.27 Billion USD. Explore cash flow conversion of Denali Therapeutics Inc to assess how effectively this company generates cash.
Annual Net Asset Quality Index for Denali Therapeutics Inc (2015–2025)
The table below presents the year-by-year Net Asset Quality Index for Denali Therapeutics Inc from 2015 to 2025, covering 11 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see DNLI market cap overview.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 88.5% | $1.01 Billion | $1.14 Billion | $131.09 Million | ▼ -0.9 pp |
| 2024 | 89.5% | $1.23 Billion | $1.37 Billion | $144.50 Million | ▲ +0.1 pp |
| 2023 | 89.3% | $1.03 Billion | $1.15 Billion | $122.96 Million | ▲ +18.0 pp |
| 2022 | 71.4% | $1.04 Billion | $1.46 Billion | $417.81 Million | ▲ +2.9 pp |
| 2021 | 68.5% | $962.29 Million | $1.40 Billion | $441.87 Million | ▼ -3.2 pp |
| 2020 | 71.7% | $1.15 Billion | $1.60 Billion | $453.75 Million | ▲ +0.3 pp |
| 2019 | 71.4% | $394.89 Million | $553.23 Million | $158.34 Million | ▼ -11.2 pp |
| 2018 | 82.6% | $546.85 Million | $661.98 Million | $115.14 Million | ▼ -13.1 pp |
| 2017 | 95.7% | $465.80 Million | $486.72 Million | $20.93 Million | ▲ +1.8 pp |
| 2016 | 93.9% | $254.52 Million | $271.07 Million | $16.55 Million | ▲ +136.5 pp |
| 2015 | -42.6% | $-15.63 Million | $36.68 Million | $52.32 Million | — |